Literature DB >> 10465150

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis.

M Nishikawa1, T Ichiyama, T Hayashi, K Ouchi, S Furukawa.   

Abstract

Three children ranging in age from 2 to 5 years with acute disseminated encephalomyelitis (ADEM) were successfully treated with high-dose intravenous immunoglobulin (IVIG). Their symptoms were somnolence, fever, headache, vomiting, and resting tremor. In all of these patients, it was difficult to distinguish the condition from viral encephalitis before analyzing the myelin basic protein. ADEM was diagnosed because of increased levels of myelin basic protein in their cerebrospinal fluid and abnormal high-signal intensity on T2-weighted magnetic resonance imaging. All patients were given IVIG at a dose of 400 mg/kg/day for 5 consecutive days. The patients rapidly regained consciousness in 14 hours, 2 days, and 4 days and demonstrated a complete clinical improvement within 18 days, 10 days, and 7 days of the initiation of the treatment, respectively. IVIG may prove useful as an alternative treatment to corticosteroids for ADEM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465150     DOI: 10.1016/s0887-8994(99)00042-9

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  28 in total

1.  Acute demyelinating disorders of the central nervous system.

Authors:  Meghan K Harris; Amir Hadi Maghzi; Masoud Etemadifar; Roger E Kelley; Eduardo Gonzalez-Toledo; Alireza Minagar
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

2.  Clinically isolated syndrome and multiple sclerosis: rethinking the arsenal.

Authors:  Krupa Pandey; Fred D Lublin
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

3.  Acute Disseminated Encephalomyelitis (ADEM) Presenting with Bilateral Optic Neuritis.

Authors:  Sapiah Sapuan; Hamidon Basri
Journal:  Malays J Med Sci       Date:  2007-01

Review 4.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

5.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

6.  IVIG treatment for VZV-related acute inflammatory polyneuropathy in a child.

Authors:  Danilo Buonsenso; Benedetta Focarelli; Piero Valentini; Roberta Onesimo
Journal:  BMJ Case Rep       Date:  2012-07-19

7.  Extensive acute disseminated encephalomyelitis in a young girl responding to intravenous methylprednisolone.

Authors:  Rajesh Verma; Tushar B Patil; Rakesh Lalla; Manoj Kumar
Journal:  BMJ Case Rep       Date:  2013-10-03

Review 8.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

Review 9.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 10.  Pediatric multiple sclerosis.

Authors:  Dorothée Chabas; Ari J Green; Emmanuelle Waubant
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.